Company / CapEx per Share
Tarsus Pharmaceuticals, Inc. CapEx per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.26
FY2025
5-year range
$0.03 / $0.26
FY2021-FY2025
Trend
+461.3%
vs FY2024
Sector context
#41 of 192
Health Care
What the data says
CapEx per Share changed +461% YoY in FY2025, a notable deviation from the 6-year average annual change of +80%.
Based on SEC 10-K filings.
0.26 in FY2025 with a 5-year CAGR of +28.5%. Top quartile in the Health Care sector.
Improved from $0.06 to $0.26 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- +108.6%
- 5-Year CAGR
- +28.5%
- 10-Year CAGR
- -
Sector benchmark
Top 21% in Health CareTop 21% of 192This company $0.26 Sector average $3.54
▼
-92.7% below sector average
Key checks
Key Insights
- In FY2025, capex per share increased 461.3% year-over-year.
- Ranks #41 out of 192 companies in the Health Care sector.
- Lowest capex per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.92 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.26 | +461.3% |
| FY2024 | $0.05 | -18.6% |
| FY2023 | $0.06 | +98.7% |
| FY2022 | $0.03 | -1.8% |
| FY2021 | $0.03 | -60.7% |
| FY2020 | $0.07 | -0.8% |
| FY2019 | $0.07 | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026